TY - JOUR
T1 - Prediction of resistance to intravenous immunoglobulin in children with Kawasaki disease
AU - Israeli Kawasaki Group
AU - Bar-Meir, Maskit
AU - Kalisky, Itai
AU - Schwartz, Andrei
AU - Somekh, Eli
AU - Tasher, Diana
AU - Ashkenazi, Shai
AU - Averbuch, Diana
AU - Miron, Dan
AU - Guri, Alex
AU - Stein, Michal
AU - Greenberg, David
AU - Glikman, Daniel
AU - Efrat, Moshe
AU - Chaim, Barak
AU - Youngster, Ilan
AU - Barzilai, Asher
AU - Srugo, Itzhak
AU - Shachor-Meyouhas, Yael
N1 - Publisher Copyright:
© The Author(s) 2017. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved.
PY - 2018/2/19
Y1 - 2018/2/19
N2 - Background. Approximately 10%-20% of patients with Kawasaki disease (KD) are refractory to initial intravenous immunoglobulin (IVIg) therapy, and these "nonresponders" are at higher risk of coronary artery abnormalities. Early identification of these patients, who may benefit from additional therapy, is challenging. The aim of the present study is to identify predictors for IVIg resistance. Methods. We reviewed clinical records of 312 consecutive KD patients from 9 medical centers in Israel (development dataset) and 186 patients from additional 5 centers (validation dataset). Using multivariate analysis, we identified predictors of IVIg resistance. A third small prospective cohort of consecutive KD patients from a single medical center was used to test the accuracy of the predictors. Results. Coronary artery abnormalities in the initial echocardiogram and presenting before day 5 of fever were independent predictors of IVIg nonresponse. Using either of these variables generated an area under the receiver-operating-characteristics curve of 0.7 (95% confidence interval [CI], 0.6-0.8). Sensitivity to predict nonresponse was 81% (95% CI, 67-90) and specificity was 50% (95% CI, 44-56). Similar results were found in the validation dataset and in the small prospective cohort. Conclusions. Coronary artery abnormalities in the initial echocardiogram and presenting before day 5 of fever show high sensitivity in identifying IVIg nonresponders among our KD patients.
AB - Background. Approximately 10%-20% of patients with Kawasaki disease (KD) are refractory to initial intravenous immunoglobulin (IVIg) therapy, and these "nonresponders" are at higher risk of coronary artery abnormalities. Early identification of these patients, who may benefit from additional therapy, is challenging. The aim of the present study is to identify predictors for IVIg resistance. Methods. We reviewed clinical records of 312 consecutive KD patients from 9 medical centers in Israel (development dataset) and 186 patients from additional 5 centers (validation dataset). Using multivariate analysis, we identified predictors of IVIg resistance. A third small prospective cohort of consecutive KD patients from a single medical center was used to test the accuracy of the predictors. Results. Coronary artery abnormalities in the initial echocardiogram and presenting before day 5 of fever were independent predictors of IVIg nonresponse. Using either of these variables generated an area under the receiver-operating-characteristics curve of 0.7 (95% confidence interval [CI], 0.6-0.8). Sensitivity to predict nonresponse was 81% (95% CI, 67-90) and specificity was 50% (95% CI, 44-56). Similar results were found in the validation dataset and in the small prospective cohort. Conclusions. Coronary artery abnormalities in the initial echocardiogram and presenting before day 5 of fever show high sensitivity in identifying IVIg nonresponders among our KD patients.
KW - Coronary arteries
KW - Glucocorticoids
KW - Sensitivity
KW - Specificity
UR - http://www.scopus.com/inward/record.url?scp=85018194223&partnerID=8YFLogxK
U2 - 10.1093/jpids/piw075
DO - 10.1093/jpids/piw075
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 28062554
AN - SCOPUS:85018194223
SN - 2048-7193
VL - 7
SP - 25
EP - 29
JO - Journal of the Pediatric Infectious Diseases Society
JF - Journal of the Pediatric Infectious Diseases Society
IS - 1
ER -